Absci Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Absci Corp 公司

Absci Corporation 是一家數據優先的生成人工智能 (AI) 藥物創造公司。該公司將 AI 與可擴展的溼實驗室技術相結合，爲患者創造生物製劑。該公司的綜合藥物創造平臺通過同時優化對開發和治療效益都很重要多種藥物特性，釋放了加快臨牀時間和提高成功概率的潛力。通過訓練數據、創造 AI 和驗證溼實驗室，其綜合藥物創造平臺旨在設計生物製劑。該公司正在開發一個多元化的項目組合，重點是細胞因子生物學。它有三個專注於細胞因子生物學的全資內部管線項目，以及幾個正在評估的其他未公開的管線項目。其全資管線項目包括 ABS-101、ABS-201 和 ABS-301。該公司的其他管線項目包括 ABS-501 和其他藥物創造項目。

Absci Corp簡介



公司代碼ABSI

公司名稱Absci Corp

上市日期Jul 22, 2021

CEOMr. Sean Mcclain

員工數量156

證券類型Ordinary Share

年結日Jul 22

公司地址18105 Se Mill Plain Blvd

城市VANCOUVER

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編98683

電話13609491041

網址https://www.absci.com/

公司代碼ABSI

上市日期Jul 22, 2021

CEOMr. Sean Mcclain

Absci Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Sean Mcclain

Chief Executive Officer, Founder, Director

8.70M

-0.27%

Mr. Andreas Busch, Ph.D.

Chief Innovation Officer

128.39K

-2.35%

Dr. Zachariah (Zach) Jonasson, Ph.D.

Chief Financial Officer, Chief Business Officer

124.91K

-0.31%

Ms. Shelby J. Walker, J.D.

Chief Legal Officer

59.30K

--

Ms. Karen K. Mcginnis, CPA

Independent Director

29.50K

+96.67%

Mr. Daniel A. (Dan) Rabinovitsj

Independent Director

14.50K

--

Ms. Mary T. Szela

Director

--

Mr. Frans Van Houten

Independent Chairman of the Board

--

-100.00%

Prof. Dr. Menelas (Mene) Pangalos, Ph.D.

Independent Director

--

Dr. Joseph Sirosh, Ph.D.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Sean Mcclain

Chief Executive Officer, Founder, Director

8.70M

-0.27%

Mr. Andreas Busch, Ph.D.

Chief Innovation Officer

128.39K

-2.35%

Dr. Zachariah (Zach) Jonasson, Ph.D.

Chief Financial Officer, Chief Business Officer

124.91K

-0.31%

Ms. Shelby J. Walker, J.D.

Chief Legal Officer

59.30K

--

Ms. Karen K. Mcginnis, CPA

Independent Director

29.50K

+96.67%

Mr. Daniel A. (Dan) Rabinovitsj

Independent Director

14.50K

--

收入明細

暫無數據

暫無數據

業務

地區

暫無數據

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

Fidelity Management & Research Company LLC

12.80%

ARK Investment Management LLC

6.72%

McClain (Sean)

5.82%

Redmile Group, LLC

5.52%

BlackRock Institutional Trust Company, N.A.

4.98%

其他

64.16%

持股股東

佔比

Fidelity Management & Research Company LLC

12.80%

ARK Investment Management LLC

6.72%

McClain (Sean)

5.82%

Redmile Group, LLC

5.52%

BlackRock Institutional Trust Company, N.A.

4.98%

其他

64.16%

股東類型

持股股東

佔比

Investment Advisor

35.64%

Investment Advisor/Hedge Fund

18.75%

Individual Investor

6.26%

Hedge Fund

3.58%

Corporation

3.17%

Research Firm

2.18%

Bank and Trust

0.28%

Venture Capital

0.16%

Insurance Company

0.03%

其他

29.95%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

297

90.86M

60.76%

-3.89M

2025Q2

309

100.84M

69.96%

-2.94M

2025Q1

316

100.15M

78.58%

-546.74K

2024Q4

298

92.04M

80.13%

-8.74M

2024Q3

280

90.06M

79.27%

-8.98M

2024Q2

257

91.26M

83.61%

+4.72M

2024Q1

236

84.09M

77.41%

+14.50M

2023Q4

202

58.01M

62.41%

-6.63M

2023Q3

196

57.87M

62.40%

-7.67M

2023Q2

191

58.28M

63.02%

-12.48M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Fidelity Management & Research Company LLC

19.13M

12.8%

+747.00K

+4.06%

Jun 30, 2025

ARK Investment Management LLC

10.05M

6.72%

-909.16K

-8.30%

Jun 30, 2025

McClain (Sean)

8.73M

5.84%

+119.00K

+1.38%

Mar 31, 2025

Redmile Group, LLC

8.25M

5.52%

--

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

7.45M

4.98%

+1.20M

+19.14%

Jun 30, 2025

The Vanguard Group, Inc.

6.45M

4.31%

+1.76M

+37.63%

Jun 30, 2025

Phoenix Ventures Partners II LP.

4.75M

3.17%

-4.61M

-49.28%

Mar 31, 2025

Fred Alger Management, LLC

3.93M

2.63%

-364.72K

-8.49%

Jun 30, 2025

Woodline Partners LP

2.97M

1.98%

+1.57M

+113.20%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.45M

1.64%

+448.98K

+22.49%

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

ARK Genomic Revolution ETF

3.03%

WisdomTree BioRevolution Fund

1%

iShares Micro-Cap ETF

0.08%

ProShares Ultra Nasdaq Biotechnology

0.05%

Invesco Nasdaq Biotechnology ETF

0.04%

iShares Biotechnology ETF

0.04%

iShares Russell 2000 Growth ETF

0.02%

Avantis US Small Cap Equity ETF

0.02%

Proshares Ultra Russell 2000

0.01%

ProShares Hedge Replication ETF

0.01%

ARK Genomic Revolution ETF

佔比3.03%

WisdomTree BioRevolution Fund

佔比1%

iShares Micro-Cap ETF

佔比0.08%

ProShares Ultra Nasdaq Biotechnology

佔比0.05%

Invesco Nasdaq Biotechnology ETF

佔比0.04%

iShares Biotechnology ETF

佔比0.04%

iShares Russell 2000 Growth ETF

佔比0.02%

Avantis US Small Cap Equity ETF

佔比0.02%

Proshares Ultra Russell 2000

佔比0.01%

ProShares Hedge Replication ETF

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據